SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biogen
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
1686 75 0 BIIB
Emcee:  Harold Engstrom Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1336To:Cacaito who wrote (15439) From: Bluegreen Sunday, Jun 24, 2001 11:32 PM ResBluegreen-6/24/2001
1335Bluegreen, I think you have a point but even if safety is not an issue it shouldaknahow-6/24/2001
1334George, it is hilarious how some think there is no difference between blocking aBluegreen-6/24/2001
1333I think Harold says it all very well. What some may not understand is that the aknahow-6/24/2001
1332NO NO NO. You are not better off by destroying T cells ANY T CELLS!!!!!! DESTRBluegreen-6/24/2001
1331Nice piece of work, Harold. Very well said. I hope that this puts to rest a lot Mark Bong-6/24/2001
1330Disclosure: I have no position with either BGEN or XOMA, but, there are T cells Harold Engstrom-6/24/2001
1329George, how does Biogen intend to treat Psoriasis for life of the patient???? ABluegreen-6/24/2001
1328Cacaito, if I were the FDA I would demand to see some LONG TERM data on destroyiBluegreen-6/24/2001
1327So What the IV form "hearsay and alleged" less activity, maybe due to Cacaito-6/24/2001
1326On 12 June BGEN filed this with the S.E.C. BIOGEN COMPLETES PHASE III aknahow-6/24/2001
1325CACAITO!!! Have you read the article on Xoma at BLOOMBERG by REED???? Now how Bluegreen-6/23/2001
1324I did not say that. I said let the doctors use whatever they and their patientsaknahow-6/22/2001
1323Gw, it is like what you said about bpi, let it be free for the clinicians to decCacaito-6/22/2001
1322Did you or did you not listen to the BGEN Q&A on Amevive? Will they be firsaknahow-6/22/2001
1321Gw, Here a very Happy Biogen holder. Zero outrage. Biogen came from pII (at the Cacaito-6/22/2001
1320Another potential player in the field, early stage, is Vasogen (VAS TSE, MEW ASEFred McCutcheon-6/22/2001
1319Mark, I would be furious with XOMA management if they had allowed their drug to aknahow-6/22/2001
1318Thanks George. While not a big sissy, I prefer shorter needles. MEDI-507 is Harold Engstrom-6/22/2001
1317TSC's take on the issue thestreet.comtom pope-6/21/2001
1316cacaito, teach me something for future use also. I see that the Amevive dose waaknahow-6/21/2001
1315TIA, mean xanelim. Blood perfusion recovered! xanelim patients treated themselvCacaito-6/21/2001
1314Please show me where it says this. I missed it. TIAaknahow-6/21/2001
1313Amevive patients 10 to 18 months responses. Very humane! Amevive patients in thCacaito-6/21/2001
1312The schedule was once a week for 12 weeks, for both Amevive and Xanelim. The Biaknahow-6/21/2001
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News